A PEER-REVIEWED JOURNAL OF RESEARCH AND CLINICAL MEDICINEISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

Laboratory Dynamics in Children With Mild Persistent Bronchial Asthma

DOI:10.31550/1727-2378-2020-19-10-48-51
For citation: Fedorov I.A., Rybakova O.G. Laboratory Dynamics in Children With Mild Persistent Bronchial Asthma. Doctor.Ru. 2020; 19(10): 48–51. (in Russian). DOI: 10.31550/1727-2378-2020-19-10-48-51
30 november 2020

Study Objective: to track the laboratory dynamics in children with mild persistent bronchial asthma (BA) at various stages of disease with or without baseline therapy.

Study Design: prospective cohort study.

Materials and Methods. The study included 42 patients with mild persistent BA aged 5 to 16 years. Each child was followed up for 3 years. At initiation of the study and during each visit, all patients had their blood eosinophils, nasal discharge (ND) and induced sputum (IS), as well as serum eosinophil cation protein (ECP) tested; and their respiratory function was assessed. All children were prescribed baseline therapy with low doses of inhalative glucocorticosteroids (GCS); 18 children also received allergen-specific immunotherapy (ASIT).

Study Results. Inhalative GCS for BA exacerbations facilitated normalisation of sputum, ND and blood eosinophils. During periods of BA remission, ND and IS eosinophil levels increased, but patients did not have rhinitis and BA symptoms. Eosinophil levels in IS were higher vs. BA control (р = 0.05) and lower vs. disease exacerbations (р < 0.05). We did not find any differences in laboratory results in children with or without ASIT who were treated with low doses of inhalative and nasal GCS.

Conclusion. Eosinophile inflammatory phenotype in patients did not charge depending on disease duration and control therapies. According to the study data, eosinophile levels in IS, when BA exacerbation was recorded, were 8.0% [3.0–16.0%]. This value can be used as an additional predictor for the need in increased therapy (a step forward). Irrespective of the disease stage and therapy, there was correlation between blood eosinophile level and IS eosinophile level and between IS eosinophile level and blood ECP concentration.

Contributions: Fedorov, I.A. — study design and planning; approval of the manuscript for publication; Rybakova, O.G. — patient examination, raw materials collection for manuscript, information analysis, statistical data processing, manuscript preparation.

Conflict of interest: The authors declare that they do not have any conflict of interests.

I.A. Fedorov (Corresponding author) — South Ural State Medical University of the Ministry of Health of the Russian Federation; 64 Vorovsky Str., Chelyabinsk, Russian Federation 454092. eLIBRARY.RU SPIN: 4305-6948. E-mail: ifedorov@mail.ru

O.G. Rybakova — South Ural State Medical University of the Ministry of Health of the Russian Federation; 64 Vorovsky Str., Chelyabinsk, Russian Federation 454092. eLIBRARY.RU SPIN: 1334-6396. E-mail: gallo53@mail.ru

Доктор.ру

Table

Laboratory results of children depending on the clinical settings

t9_1.jpg

* Statistically significant differences vs. stage I (p < 0.05).** Statistically significant differences vs. stage IV (p < 0.05).

*** Statistically significant differences vs. stage II (p = 0.05).

Received: 02.07.2020

Accepted: 23.09.2020

30 November 18:26
REFERENCES
  1. Zhakov Ya.I., Rybakova O.G., Kulichkov V.I. et al. Diagnosis of bronchial asthma in infants using induced sputum cytology: patent 2407451 RF No. 2009117008. Application dated 04/05/2009; published on 27/12/2010. Newsletter No. 36. 14 p. (in Russian)
  2. Mizernitskiy Yu.L., Zhakov Ya.I., Minina E.E. et al. Nitrogen oxide metabolite levels in induced sputum: comparison in children with recurrent obstructive bronchitis and bronchial asthma. Russian Journal of Immunology. 2008; 1: 179–80. Supple 1: Proceedings of the National conference “Allergology and clinical immunology: interdisciplinary problems”. (in Russian)
  3. Fedorov I.A., Rybakova O.G., Stepanov O.G. Diagnosed bronchial asthma in children with known episodes of acute bronchitis at an early age: evidence based on ten years of experience. Human. Sport. Medicine. 2017; 17(1): 28–35. (in Russian). DOI: 10.14529/hsm170103
  4. Gao W., Han G.J., Zhu Y.J. et al. Clinical characteristics and biomarkers analysis of asthma inflammatory phenotypes. Biomarkers in Medicine. 2020; 14(3): 211–22. DOI: 10.2217/bmm-2019-0487
  5. Suárez-Cuartín G., Crespo A., Mateus E. et al. Variability in asthma inflammatory phenotype in induced sputum. Frequency and causes. Arch. Bronconeumol. 2016; 52(2): 76–81. DOI: 10.1016/j.arbres.2015.03.007
  6. Hilvering B., Vijverberg S.J.H., Jansen J. et al. Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness. Allergy. 2017; 72(8): 1202–11. DOI: 10.1111/all.13117
  7. Green R.H., Pavord I. Stability of inflammatory phenotypes in asthma. Thorax. 2012; 67(8): 665–7. DOI: 10.1136/thoraxjnl-2012-201657
  8. Henderson A.J. Childhood asthma phenotypes. Breathe. 2014; 10(2): 101–8. DOI: 10.1183/20734735.014613
  9. Asiryan E.G., Titova N.D. Characteristic of the eosinophilic phenotype of bronchial asthma in children. Immunopathology, Allergology, Infectology. 2017; 1: 52–7. (in Russian). DOI: 10.14427/jipai.2017.1.52
  10. Li H.W., Lin J.T., Nong Y. et al. Distribution of airway inflammation phenotype in patients with bronchial asthma and its correlation with control level. Zhonghua Yixeuehui Zazhishe. 2019; 99(22): 1692–7. DOI: 10.3760/cma.j.issn.0376-2491.2019.22.002
  11. Pijnenburg M.W., Baraldi E., Brand P.L.P. et al. Monitoring asthma in children. Eur. Respir. J. 2015; 45(4): 906–25. DOI: 10.1183/09031936.00088814
  12. Korten I., Zacharasiewicz A., Bittkowski N. et al. Asthma control in children: body plethysmography in addition to spirometry. Pediatr. Pulmonol. 2019; 54(8): 1141–8. DOI: 10.1002/ppul.24320
  13. Mukhametzyanova V.G., Rybakova O.G. Experience in use of sublingual vaccine “Staloral” in children. Russian Journal of Immunology. 2017; 11(20–4): 731–3. (in Russian)
  14. Walsh C.J., Zaihra T., Benedetti A. et al. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils. Clin. Exp. Allergy. 2016; 46(10): 1291–302. DOI: 10.1111/cea.12762
  15. Fleming L., Tsartsali L., Wilson N. et al. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax. 2012; 67(8): 675–81. DOI: 10.1136/thoraxjnl-2011-201064

Похожие статьи

News

1 October 10:52
A New Issue of Doctor.Ru Internal Medicine, Vol. 21, No. 6 (2022), Published

Find original articles and reviews covering various aspects of сardiology, gastroenterology, internal medicine and the interview with Professor Alexey Nikolaevich Kalyagin

7 July 17:16
A New Issue of Doctor.Ru Neurology Psychiatry, Vol. 21, No. 4 (2022), Published

Find original articles and reviews covering various aspects of neurology, psychiatry and the interview with Professor Alexander Vitalievich Amelin

12 May 11:25
A New Issue of Doctor.Ru Pediatrics, Vol. 21 No. 3 (2022), Published

See the original papers, reviews and clinical cases in headings Pulmonology, Rheumatology, Endocrinology, Neurology, Cross-disciplinary approach and Interview with with an Honoured Scientist of the Sakha (Yakutia) Republic Professor Maria Vasilievna Khandy

4 May 10:02
A New Issue of Doctor.Ru Internal Medicine, Vol. 21, No. 2 (2022), Published

Find original articles and reviews covering various aspects of gastroenterology, internal medicine, rheumatology, endocrinology, special section of postgraduate training and the interview with Professor Dmitry Alexeevich Sychev

18 March 00:00
A New Issue of Doctor.Ru Gynecology, Vol. 21 No. 1 (2022), Published

Find original articles and reviews covering various aspects of obstetrics, perinatology and gynecology, and the interview with Feldberg Dov, MD

All news